Previous experiments demonstrated that the transcriptional amplification system PSEBC-TSTA-fl is able to specifically quantify androgen receptor (AR) activity modulation in vitro and in vivo in prostate cancer cells [22, 23]. The gene discussed is AR; the disease is prostate carcinoma.